Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. - Test2 - elhamkhani - TriplyDB

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

http://www.wikidata.org/entity/Q33913953

about

Combination chemotherapy versus single-agent chemotherapy during preoperative chemoradiation for resectable rectal cancer Sequential versus combination chemotherapy for advanced colorectal cancer Combination chemotherapy versus single agent chemotherapy during preoperative chemoradiation for resectable rectal cancer Anti-angiogenic therapies for metastatic colorectal cancer Anti-angiogenic therapy for metastatic colorectal cancer Chemotherapy with platinum compounds for metastatic colorectal cancer Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients Patients' expectations about effects of chemotherapy for advanced cancer Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancers Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer Phase I study of intermittent and chronomodulated oral therapy with capecitabine in patients with advanced and/or metastatic cancer.Advances in targeted and immunobased therapies for colorectal cancer in the genomic era Evidence-based medical oncology and interventional radiology paradigms for liver-dominant colorectal cancer metastases.Single Nucleotide Polymorphisms as Prognostic and Predictive Factors of Adjuvant Chemotherapy in Colorectal Cancer of Stages I and II Pharmacologic resistance in colorectal cancer: a review Multimodality treatment strategies have changed prognosis of peritoneal metastases Advances in drug delivery system for platinum agents based combination therapy Adjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysis Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer A Systematic Review and Network Meta-Analysis of Biologic Agents in the First Line Setting for Advanced Colorectal Cancer Precision medicine in colorectal cancer: the molecular profile alters treatment strategies Management of colorectal cancer FOLFOX/FOLFIRI pharmacogenetics: the call for a personalized approach in colorectal cancer therapy Pulmonary metastasectomy for colorectal cancer: how many nodules, how many times?Review of systemic therapies for locally advanced and metastatic rectal cancer Management of locally advanced and metastatic colon cancer in elderly patients Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity Identification of clinically relevant molecular subtypes in colorectal cancer: the dawning of a new era The unfolded protein response regulator GRP78 is a novel predictive biomarker in colorectal cancer.RAS and BRAF in metastatic colorectal cancer management Unresolved issues and controversies surrounding the management of colorectal cancer liver metastasis The changing face of chemotherapy in colorectal cancer Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) +/- folinic acid in a compassionate-use cohort of 481 5-FU-resistant advanced colorectal cancer patients Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancer Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer A novel and selective poly (ADP-ribose) polymerase inhibitor ameliorates chemotherapy-induced painful neuropathy

P2860

Q24186443-029B1F3C-C02F-4875-B229-CE9BC3A76E38 Q24234461-D9AFC7D1-8129-4F94-ACF6-7AC15009D753 Q24235103-70CE17C2-A11B-4289-BD3B-4D27A8A4784D Q24241813-80300428-1B3D-44C6-9781-6E1E378FFE61 Q24243297-5DF0063C-83DF-418E-8018-D8CCEBB6ACBB Q24250512-10BDB59B-8279-48DC-84E5-0DF27A46D120 Q24561669-9446E3FF-071A-47DE-9676-1691ED3684D4 Q24597282-C7B435AF-C0CD-4063-B080-86EA0F6C8FC0 Q24647888-2FA67B9E-DDBA-47CE-AB98-97A90A684363 Q24651894-4BAE9967-55B7-40A1-B969-7F57CAA99EA5 Q24792155-49898B87-A899-4AC2-8C8B-607B35F81D17 Q24795784-1BC0D72A-FD59-432C-988A-2521A2F01897 Q24815800-A4E68D48-0E64-44CF-8A50-C9613E900647 Q25256709-CD45D5F5-DB58-41F8-82EE-C4FCA4E769B5 Q26751344-28B2C3A0-C2B6-4A50-BA67-61ED883412DC Q26752747-3F4215B7-5E32-4C4C-BAC5-6826D389555F Q26765344-8C47154E-D544-4CDB-B1DC-8DA20B9A5132 Q26769850-5A1CC1D8-2D3D-42FC-9926-DFB14E188C72 Q26769938-52125416-9D29-441E-84D7-71C418020D7E Q26771390-12BF4EA9-C3BA-4023-A4CF-A80C3D6B312C Q26774704-8B2CA979-5378-4E5D-8315-E63101AA856C Q26775949-5C4AB646-AB6F-45F5-B3E0-D2F0AF5A68CD Q26782245-21C77948-3D67-4FE8-85E6-A69F64EEA59D Q26795558-F128D947-349B-4F98-B90F-5F70C57AC00B Q26823550-218B6F5B-7AD7-4112-A22C-52B29E4E072C Q26851060-DAB96D09-ED9F-4052-8B82-816487F85FA3 Q26859632-CC2F8CCD-AB71-4291-B1F2-0E5219198091 Q27021105-77940FAF-0EB0-437E-96C1-AC9285392415 Q27026129-296E52E6-8CF8-4746-86D5-EB1CBA58F30E Q27305830-E7A41F81-B4EB-404D-BE87-533C34C0ECB5 Q27693248-AC9BE937-26F5-42DA-BCFC-E8122587AE61 Q27852108-3D73633E-4841-42C8-B320-9657D6C487FD Q28074175-9D345B0D-D803-49C0-9DCA-2807F33A6504 Q28085651-A8F27D54-ED36-4C69-B72B-7DD897C39A22 Q28345461-82FEEF62-2CC8-477B-8FF4-F6B43AA0CE83 Q28346039-E56F12CF-F83C-4B84-BC2F-C5AEB5870371 Q28350941-631AA2F3-B3B6-4EDD-A9A3-F4A5363F9E90 Q28359438-C3EB7071-1A22-45E8-A6FB-A3CD8AE4FF67 Q28364999-5551DA60-3718-4669-A6DC-7EC84AE40F10 Q28484947-8A4C6A72-3A83-4655-AD1A-9E8BB824FFC2

P2860

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

http://www.wikidata.org/entity/Q33913953

description

2000 nî lūn-bûn

@nan

2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Leucovorin and fluorouracil wi ...... in advanced colorectal cancer.

@ast

Leucovorin and fluorouracil wi ...... in advanced colorectal cancer.

@en

type

label

Leucovorin and fluorouracil wi ...... in advanced colorectal cancer.

@ast

Leucovorin and fluorouracil wi ...... in advanced colorectal cancer.

@en

prefLabel

Leucovorin and fluorouracil wi ...... in advanced colorectal cancer.

@ast

Leucovorin and fluorouracil wi ...... in advanced colorectal cancer.

@en

P1433

Q33913953-BD247537-0C2E-4433-9EEC-2F05D2184BC6

P1476

Q33913953-E5293BB2-C495-4DB6-A118-C1CB4FC903B2

P2093

Q33913953-029E813F-ED64-4F17-BECA-D6C876C6B06E

Q33913953-02E055C5-6B74-4DC0-BB64-CC48BA77324C

Q33913953-1070F0DA-9253-44F6-8A9C-A484E46F46BE

Q33913953-265F970A-2255-40D6-BB98-AB4A5F166F9D

Q33913953-33034D4C-0872-4A0F-8A9B-56DCD2B02BE9

Q33913953-3B8433E4-8C58-489E-A603-BDBFB89FE0B5

Q33913953-46374B61-B649-41EB-808F-75DB96A1AB37

Q33913953-48E1ED5F-BF1B-4129-BC1C-45F8DAAC859A

Q33913953-510CB9F8-9592-4EF9-9C98-7D8B6D0CC848

Q33913953-5187205C-AB76-46BB-98BB-54E5EF7B70C5

P304

Q33913953-EA80529A-C671-49D6-B0AF-F14D351BF4B9

P31

Q33913953-ABD34D2B-6391-40E2-A658-01C3BE3A0586

P356

Q33913953-85C4E2B1-90F7-4D6F-BE6C-B9A17FEB7CBD

P407

Q33913953-E4149000-A54B-444A-8D31-7BBBF5E9565B

P433

Q33913953-4BFDB367-9486-4BFE-9E52-14936DFB37D1

P478

Q33913953-3ABF58A3-BBF9-437D-A2EF-EE931CBB123A

P577

Q33913953-7FA48C5D-1C51-472B-82F4-A1DD85A17EE2

P698

Q33913953-865DC67E-0D7C-4E3F-ACA2-625F4EF51A08

P921

Q33913953-72607FCE-62C7-4A73-83DE-A78062B16B1F

P356

JCO.2000.18.16.2938

P1433

Journal of Clinical Oncology

P1476

Leucovorin and fluorouracil wi ...... in advanced colorectal cancer.

@en

P2093

A Bonetti

http://www.w3.org/2001/XMLSchema#string

A Cervantes

http://www.w3.org/2001/XMLSchema#string

A Figer

http://www.w3.org/2001/XMLSchema#string

A Hmissi

http://www.w3.org/2001/XMLSchema#string

A de Gramont

http://www.w3.org/2001/XMLSchema#string

C Boni

http://www.w3.org/2001/XMLSchema#string

C Louvet

http://www.w3.org/2001/XMLSchema#string

C Wilson

http://www.w3.org/2001/XMLSchema#string

D Hendler

http://www.w3.org/2001/XMLSchema#string

D Papamichael

http://www.w3.org/2001/XMLSchema#string

P304

2938-2947

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2000.18.16.2938

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2000-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10944126

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer